SRC8 Antibody (N-term) Blocking Peptide

SRC8 Antibody (N-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP9247a
Catalog Number: AC-BP9247a
Size: 500 µg
Datasheet
Request Information
Background:
SRC8 is overexpressed in breast cancer and squamous cell carcinomas of the head and neck. The encoded protein is localized in the cytoplasm and in areas of the cell-substratum contacts. This protein has two roles: (1) regulating the interactions between components of adherens-type junctions and (2) organizing the cytoskeleton and cell adhesion structures of epithelia and carcinoma cells. During apoptosis, the encoded protein is degraded in a caspase-dependent manner. The aberrant regulation of this protein contributes to tumor cell invasion and metastasis.

Other Names:
Src substrate cortactin, Amplaxin, Oncogene EMS1, CTTN, EMS1

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9247a was selected from the N-term region of human SRC8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: CTTN

Gene ID: 2017
Primary Accession: Q14247
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:SRC8 Antibody (N-term) Blocking Peptide